Egg-Freezing Not the Answer for Young Women's Fertility Insurance

By Sharon Smith
Monday, 29 June, 2015


Women have been encouraged to freeze their eggs (or cryptopreservation) for a variety of reasons for some time now: as a pre-cursor to fertility-ending treatments, for assistance during long and drawn out fertility treatments, and even for social reasons centred around family planning.
However in light of recent news of companies offering cryptopreservation to employees and even parents giving their daughters fertility preservation as a 21st birthday preservation according to the Sydney Morning Herald.
Dr Chris Copeland of the Canberra Fertility Clinic says egg-freezing technology was not developed for young women to pursue their careers and put their families on hold, but rather to assist those at the end of their fertility window in conceiving their long-sought-after family.
An article in the Canadian Medical Association Journal agrees that cryptopreservation has developed a social problem when used ‘improperly’.
Co-author of the article Dr Arthur Leader places the onus on physicians providing fertility advice.
“We’re not opposed to [cryptopreservation]. People just have to be well-counselled so that when they go into it they understand what it is that they’re undertaking.” It’s not an insurance policy, he said. “It’s not a guarantee that the eggs that are frozen are going to result in a family.”
In other fertility news, the use of non-steroidal anti-inflammatories (NSAIDs) has been linked to irregular ovulation in a study carried out by the University of Baghdad in Iraq.
“Each time an egg is released, it is basically a small rupture of a dominant follicle of the ovary,” said researcher Professor Sami Salman. “Taking NSAIDs can delay, inhibit, or block this rupture of egg release.”
And finally, The Conversation recently published a feature on male infertility and the possible link between the increased daily presence of chemicals from plastics - via the consumption of leeched phthalates by pregnant mothers-to-be

Related Articles

GenesisCare expands with $35m Northern Beaches cancer centre

The relocated centre has expanded its services with a new radiation therapy offering and access...

In Conversation with Royal Women's Hospital CEO Sue Matthews

An hour after the final call for visitors to leave, Professor Sue Matthews — now CEO of...

Global prostate cancer rates predicted to double by 2040

The number of annual prostate cancer deaths worldwide is predicted to rise by 85% from 375,000 in...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd